Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers

Cited by (331)

Items 101–200 of 331

1. MAJOR DEPRESSIVE DISORDER IN VULNERABLE GROUPS OF OLDER ADULTS, THEIR COURSE AND TREATMENT, AND PSYCHIATRIC COMORBIDITY
   Kee‐Lee Chou, Kelvin Chi‐Kin Cheung · 2013 · Depression and Anxiety
2. Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment
   Therese K. Killeen, Denise A. Hien, Aimee N. C. Campbell, Chanda Brown, Cheri Hansen, Huiping Jiang, Allison N. Kristman-Valente, Christine Neuenfeldt, Nicci Rocz-de la Luz, Royce R. Sampson et al. · 2008 · Journal of Substance Abuse Treatment
3. Prospective Evaluation of the Four DSM-IV Criteria for Alcohol Abuse in a Large Population
   Marc Alan Schuckit, Tom L. Smith, George P. Danko, John R. Kramer, Jessica Godinez, Kathleen Keenan Bucholz, John I. Nürnberger, VICTOR M. HESSELBROCK · 2005 · American Journal of Psychiatry
4. Patología dual en Depresión: recomendaciones en el tratamiento
   Judit Tirado-Muñoz, Adriana Farré, Joan Ignasi Mestre-Pintó, Nestor Szerman, Marta Torrens · 2017 · Adicciones
5. Factor structure and diagnostic efficiency of the BDI-II in treatment-seeking substance users
   Paul J. Seignourel, Charles Green, Joy M. Schmitz · 2008 · Drug and Alcohol Dependence
6. Associations between Attention Deficit Hyperactivity Disorder Symptom Domains and DSM‐IV Lifetime Substance Dependence
   Katherine J. Ameringer, Adam Matthew Leventhal · 2013 · American Journal on Addictions
7. Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals
   Susan Morgello, Lydia Estanislao, Elizabeth Ryan, Pieter Gerits, David M. Simpson, Susama Verma, Alessandro Di Rocco, Victoria Sharp · 2005 · AIDS
8. Alleles of a Functional Serotonin Transporter Promoter Polymorphism Are Associated With Major Depression in Alcoholics
   Maggie J. Nellissery, Richard Feinn, Jonathan Covault, Joel E. Gelernter, Raymond F. Anton, Helen M. Pettinati, Darlene H. Moak, Timothy Mueller, Henry R. Kranzler · 2003 · Alcoholism Clinical and Experimental Research
9. Do Co-morbid Anxiety Disorders Predict Drinking Outcomes in Women with Alcohol Use Disorders?
   Farris, Samantha G., Epstein, Elizabeth E., McCrady, Barbara S., Hunter-Reel, Dorian · 2012 · Alcohol and Alcoholism
10. Characterization and sociocultural predictors of neuropsychological test performance in HIV+ Hispanic individuals.
    Mónica Rivera Mindt, Desiree Byrd, Elizabeth L. Ryan, Reuben N. Robbins, Jennifer Monzones, Alyssa Arentoft, Kaori Kubo Germano, Susan Morgello, Debra E. Henniger · 2008 · Cultural Diversity & Ethnic Minority Psychology
11. Sex-specific association of depressive disorder and transient emotional states with alcohol consumption in male and female alcoholics
    Victor M. Karpyak, Jennifer R. Geske, Daniel K. Hall‐Flavin, Larissa L. Loukianova, Terry D. Schneekloth, Michelle K. Skime, Marvin D. Seppala, George Dawson, Mark A. Frye, Doo‐Sup Choi et al. · 2019 · Drug and Alcohol Dependence
12. Substance abuse increases the risk of neuropathy in an HIV‐infected cohort
    Jessica Robinson‐Papp, Benjamin B. Gelman, Igor Grant, Elyse J. Singer, Gary R. Gensler, Susan Morgello · 2011 · Muscle & Nerve
13. Comorbilidad psicopatológica en consumidores de cocaína en tratamiento ambulatorio
    Pedro Fernando Araos, Esperanza Vergara‐Moragues, María Pedraz, Francisco Javier Pavón, Rafael Campos‐Cloute, Montserrat Calado, Juan Jesús Ruiz, Nuria García‐Marchena, Isolde Gornemann, Marta Torrens et al. · 2014 · Adicciones
14. Use of Psychotropic Medication Groups in People with Severe Mental Illness and Stressful Childhood Experiences
    Andres Ricardo Schneeberger, Kristina H. Muenzenmaier, Dorothy M. Castille, Joseph Battaglia, Bruce G. Link · 2014 · Journal of Trauma & Dissociation
15. Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV‐infected cohort: experience of the National NeuroAIDS Tissue Consortium
    Susan Morgello, Charles E. Holzer, E. Ryan, Corinna Young, M. Naseer, S. A. Castellon, Alan B. Frol, Joseph Hampton Atkinson, Benjamin B. Gelman, Igor Grant et al. · 2006 · International Journal of Methods in Psychiatric Research
16. Diagnosing comorbidity: concepts, criteria, and methods
    Sharon Samet, Edward V. Nunes, Deborah S. Hasin · 2004 · Acta Neuropsychiatrica
17. Substance abuse treatment and psychiatric comorbidity: do benefits spill over? analysis of data from a prospective trial among cocaine-dependent homeless persons
    Stefan G. Kertesz, Alok Madan, Dennis Wallace, Joseph E. Schumacher, Jesse B. Milby · 2006 · Substance Abuse Treatment Prevention and Policy
18. The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study
    María J. Marquine, Jessica L. Montoya, Anya Umlauf, Pariya L. Fazeli, Ben D. Gouaux, Robert K. Heaton, Ronald J. Ellis, Scott Lee Letendre, Igor Grant, David J. Moore · 2016 · Clinical Infectious Diseases
19. Dual diagnosis: management within a psychosocial context
    Mohammed T. Abou‐Saleh · 2004 · Advances in Psychiatric Treatment
20. When Acute-Stage Psychosis and Substance Use Co-Occur: Differentiating Substance-Induced and Primary Psychotic Disorders
    Carol L. M. Caton, Sharon Samet, Deborah S. Hasin · 2000 · Journal of Psychiatric Practice
21. Higher Impulsivity As a Distinctive Trait of Severe Cocaine Addiction among Individuals Treated for Cocaine or Alcohol Use Disorders
    Nuria García‐Marchena, David Ladrón de Guevara‐Miranda, María Pedraz, Pedro Fernando Araos, Gabriel Rubio, Juan Jesús Ruiz, Francisco Javier Pavón, Antonia Serrano, Estela Castilla‐Ortega, Luis J. Santín et al. · 2018 · Frontiers in Psychiatry
22. Correlates of mild, moderate, and severe Alcohol Use Disorder among adults with problem substance use: Validity implications for DSM‐5
    Zachary L. Mannes, Dvora Shmulewitz, Ofir Livne, Malki Stohl, Deborah S. Hasin · 2021 · Alcoholism Clinical and Experimental Research
23. Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction
    Jonathan Pitcher, Anna Abt, Jaclyn Myers, Rachel Han, Melissa A. Snyder, Alessandro Graziano, Lindsay K. Festa, Michele A. Kutzler, Fernando Garcia, Wen‐Jun Gao et al. · 2014 · Journal of Clinical Investigation
24. Early psychosis and employment
    Robert E. Drake, Haiyi Xie, Gary R. Bond, Gregory J. McHugo, Carol L. M. Caton · 2013 · Schizophrenia Research
25. Impact of opiate addiction on neuroinflammation in HIV
    Desiree Byrd, Jacinta Murray, Gabriella Safdieh, Susan Morgello · 2012 · Journal of NeuroVirology
26. Smartphone and Mobile Application Utilization Prior to and Following Treatment Among Individuals Enrolled in Residential Substance Use Treatment
    Jennifer Dahne, Carl W. Lejuez · 2015 · Journal of Substance Abuse Treatment
27. Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence
    Nuria García‐Marchena, Francisco Javier Pavón, Antoni Pastor, Pedro Fernando Araos, María Pedraz, Pablo Romero‐Sanchiz, Montserrat Calado, Juan Suárez, Estela Castilla‐Ortega, Laura Orío et al. · 2016 · Addiction Biology
28. Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids)
    Dvora Shmulewitz, Malki Stohl, Eliana Greenstein, Stephanie Roncone, Claire A. Walsh, Efrat Aharonovich, Melanie M. Wall, Deborah S. Hasin · 2021 · Psychological Medicine
29. Prospective 2-Year Study of Emergency Department Patients With Early-Phase Primary Psychosis or Substance-Induced Psychosis
    R. Drake, C. Caton, Hai-Yi Xie, Eustace Hsu, P. Gorroochurn, Sharon Samet, D. Hasin · 2011 · American Journal of Psychiatry
30. Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview
    Hasin, Deborah, Shmulewitz, Dvora, Stohl, Malka, Greenstein, Eliana, Roncone, Stephanie, Aharonovich, Efrat, Wall, Melanie · 2020 · Drug and Alcohol Dependence
31. PROSPECTIVE STUDY OF SUBSTANCE-INDUCED AND INDEPENDENT MAJOR DEPRESSIVE DISORDER AMONG INDIVIDUALS WITH SUBSTANCE USE DISORDERS IN A NATIONALLY REPRESENTATIVE SAMPLE
    Jessica F. Magidson, Shuai Wang, Carl W. Lejuez, Miren Iza, Carlos Blanco · 2013 · Depression and Anxiety
32. A systematic review and meta-analysis of the prevalence of cocaine-induced psychosis in cocaine users
    Michel Sabé, Nan Zhao, Stefan Kaiser · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
33. Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain
    Deborah S. Hasin, Dvora Shmulewitz, Malka Stohl, Eliana Greenstein, Efrat Aharonovich, Kenneth R. Petronis, Michael Von Korff, Samyadev Datta, Nomita Sonty, Stephen Ross et al. · 2022 · American Journal of Psychiatry
34. A comparison of the symptoms and short-term clinical course in inpatients with substance-induced psychosis and primary psychosis
    Sharon Dawe, Leanne Geppert, Stefano Occhipinti, William Kingswell · 2010 · Journal of Substance Abuse Treatment
35. Depression outcome in alcohol dependent patients: An evaluation of the role of independent and substance-induced depression and other predictors
    James Foulds, J. Douglas Sellman, Simon Justin Adamson, Joseph M. Boden, Roger Mulder, Peter R. Joyce · 2014 · Journal of Affective Disorders
36. Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis
    Rosa María Maza-Quiroga, Nuria García‐Marchena, Pablo Romero‐Sanchiz, Vicente Barrios, María Pedraz, Antonia Serrano, Raquel Nogueira‐Arjona, Juan Jesús Ruiz, Maribel Soria, Rafael Campos et al. · 2017 · PeerJ
37. Gender Differences in Psychotic Disorders With Concurrent Substance Use
    Carol L. M. Caton, Haiyi Xie, Robert E. Drake, Gregory J. McHugo · 2014 · Journal of Dual Diagnosis
38. Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity
    Stella E. Panos, Hinkin, Elyse J. Singer, April Denise Thames, Patel Patel, Sinsheimer, A. C. Del Re, Benjamin B. Gelman, David J. Moore, Andrew J. Levine et al. · 2013 · Neurobehavioral HIV Medicine
39. The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons
    HNRP Group, María J. Marquine, Maiko Sakamoto, Catherine A. Dufour, Alexandra S. Rooney, Pariya L. Fazeli, Anya Umlauf, Ben D. Gouaux, Donald R Franklin, Ronald J. Ellis et al. · 2015 · Journal of NeuroVirology
40. Substance Use Disorders and Comorbid Mental Disorders in First-Time Admitted Patients from a Catchment Area
    Anne-Marit Langås, Ulrik Fredrik Malt, Stein Opjordsmoen · 2011 · European Addiction Research
41. CCL3 genotype and current depression increase risk of HIV-associated dementia
    Andrew J. Levine · 2009 · Neurobehavioral HIV Medicine
42. Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment
    Pier Paolo Pani, Emanuela Trogu, Federica Vigna‐Taglianti, Federica Mathis, Roberto Diecidue, Ursula Kirchmayer, Laura Amato, Marina Davoli, Joli Ghibaudi, Antonella Camposeragna et al. · 2014 · Annals of General Psychiatry
43. Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity
    María Pedraz, Ana Isabel Martı́n, Nuria García‐Marchena, Pedro Fernando Araos, Antonia Serrano, Pablo Romero‐Sanchiz, Juan Suárez, Estela Castilla‐Ortega, Vicente Barrios, Rafael Campos‐Cloute et al. · 2015 · PLoS ONE
44. Cocaine-Induced Psychotic Disorders: Presentation, Mechanism, and Management
    Yi‐lang Tang, Nancy L. Martin, Robert O. Cotes · 2014 · Journal of Dual Diagnosis
45. The Bipolar Patient with Comorbid Substance Use Disorder
    Mark J. Albanese, Ronald W. Pies · 2004 · CNS Drugs
46. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis
    Gabriel Rubio, Jesús Marín-Lozano, Francisco Ferre, Isabel Martínez‐Gras, Roberto Rodríguez–Jiménez, Javier Sanz, Miguel Ángel Jiménez‐Arriero, José Luís Carrasco, David Lora, Rosa Jurado Barba et al. · 2012 · Comprehensive Psychiatry
47. Functional polymorphisms in dopamine-related genes: Effect on neurocognitive functioning in HIV+ adults
    Andrew J. Levine, Janet S. Sinsheimer, Robert M. Bilder, Paul Shapshak, Elyse J. Singer · 2011 · Journal of Clinical and Experimental Neuropsychology
48. Clinical differences between cocaine-induced psychotic disorder and psychotic symptoms in cocaine-dependent patients
    Carlos Roncero, Marina Comín, Constanza Daigre, Lara Grau‐López, Nieves Martínez‐Luna, Francisco José Eiroá‐Orosa, Carmen Barral, Marta Torrens, Miguel Casas · 2014 · Psychiatry Research
49. Violent offences of methamphetamine users and dilemmas of forensic psychiatric assessment
    Yi Liu, Bo Hao, Yan‐Wei Shi, Xue Li, Xiaoguang Wang, Yefei Chen, Hu Zhao · 2017 · Forensic Sciences Research
50. Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology
    Larissa J. Mooney, Suzanne Nielsen, Andrew J. Saxon, Maureen P. Hillhouse, Christie Thomas, Albert L. Hasson, Don M. Stablein, Jennifer McCormack, Robert Lindblad, Walter W Ling · 2012 · Contemporary Clinical Trials
51. Personality Profile in Young Current Regular Users of Cocaine
    M. Jesús Herrero, Antònia Domingo‐Salvany, Marta Torrens, María Teresa Brugal, Fernando Gutiérrez, Itinere Investigators · 2008 · Substance Use & Misuse
52. HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations
    Michelle M. Jacobs, Jacinta Murray, Desiree Byrd, Yasmin L. Hurd, Susan Morgello · 2013 · Journal of NeuroVirology
53. Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder
    Nerea Requena-Ocaña, Pedro Fernando Araos, María Flores, Nuria García‐Marchena, Daniel Silva‐Peña, Jesús Aranda, Patricia Rivera, Juan Jesús Ruiz, Antonia Serrano, Francisco Javier Pavón et al. · 2021 · Scientific Reports
54. Modulation of BK Channel by MicroRNA-9 in Neurons After Exposure to HIV and Methamphetamine
    Erick T. Tatro, Shannon Hefler, Stephanie Shumaker-Armstrong, Benchawanna Soontornniyomkij, Michael Yang, Alexander Yermanos, Nina Wren, David J. Moore, Cristian L. Achim · 2013 · Journal of Neuroimmune Pharmacology
55. Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample
    Eline Borger Rognli, Jørgen G. Bramness, Svetlana Ondrasova Skurtveit, Anne Bukten · 2016 · Journal of Substance Abuse Treatment
56. Antioxidant Sestrin-2 Redistribution to Neuronal Soma in Human Immunodeficiency Virus-Associated Neurocognitive Disorders
    Virawudh Soontornniyomkij, Benchawanna Soontornniyomkij, David J. Moore, Ben D. Gouaux, Eliezer Masliah, Spencer Tung, Harry V. Vinters, Igor Grant, Cristian L. Achim · 2012 · Journal of Neuroimmune Pharmacology
57. Factors related to HIV-associated neurocognitive impairment differ with age
    Gary B. Fogel, Susanna L. Lamers, Andrew J. Levine, Miguel Valdes‐Sueiras, Michael S. McGrath, Paul Shapshak, Elyse J. Singer · 2014 · Journal of NeuroVirology
58. Anxiety and substance use: layers of complexity
    David Jonathan Castle · 2008 · Expert Review of Neurotherapeutics
59. On beyond urine: clinically useful assesment instruments in the treatment of drug dependence
    Kathleen M. Carroll, Bruce J. Rounsaville · 2002 · Behaviour Research and Therapy
60. A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres
    Linda Elise Couëssurel Wüsthoff, Helge Waal, Torleif Ruud, Rolf Wilhelm Gråwe · 2011 · BMC Psychiatry
61. Isolating Cognitive and Neurologic HIV Effects in Substance-Dependent, Confounded Cohorts: A Pilot Study
    Desiree Byrd, Jessica Robinson‐Papp, Mónica Rivera Mindt, Letty Mintz, Kathryn J. Elliott, Quenesha Lighty, Susan Morgello · 2013 · Journal of the International Neuropsychological Society
62. The Clinical Utility of ASRS-v1.1 for Identifying ADHD in Alcoholics Using PRISM as the Reference Standard
    Maria M. Reyes, Terry D. Schneekloth, Mario Javier Hitschfeld, Jennifer R. Geske, David Louis Atkinson, Victor M. Karpyak · 2016 · Journal of Attention Disorders
63. Alcohol Abuse: Adding Content to Category
    James W. Langenbucher, Christopher Stephen Martin · 1996 · Alcoholism Clinical and Experimental Research
64. Co-occurring Mental Disorders in Substance Abuse Treatment: the Current Health Care Situation in Germany
    Hanna Dauber, Barbara Braun, Tim Pfeiffer-Gerschel, Ludwig Kraus, Oliver Michael Pogarell · 2017 · International Journal of Mental Health and Addiction
65. Elevated Glutamate Levels in the Left Dorsolateral Prefrontal Cortex Are Associated with Higher Cravings for Alcohol
    Mark A. Frye, David J. Hinton, Victor M. Karpyak, Joanna M. Biernacka, Lee J. Gunderson, Jennifer R. Geske, Scott E. Feeder, Doo‐Sup Choi, John D. Port · 2016 · Alcoholism Clinical and Experimental Research
66. Characterizing cannabis-induced psychosis: A study with prepulse inhibition of the startle reflex
    Isabel Morales‐Muñoz, Rosa Jurado Barba, Guillermo Ponce, Isabel Martínez‐Gras, Miguel Ángel Jiménez‐Arriero, Stephan Moratti, Gabriel Rubio · 2014 · Psychiatry Research
67. Comorbilidad psiquiátrica y valores plasmáticos de 2-acilgliceroles en consumidores de alcohol en tratamiento ambulatorio. Análisis de las diferencias de género
    Nuria García‐Marchena, Pedro Fernando Araos, Francisco Javier Pavón, Guillermo Ponce, María Pedraz, Antonia Serrano, F. Árias, Pablo Romero‐Sanchiz, Juan Suárez, Antoni Pastor et al. · 2016 · Adicciones
68. Interpersonal Trauma Exposure, Trauma Symptoms, and Severity of Substance Use Disorder among Youth Entering Outpatient Substance Abuse Treatment
    Jennifer Cole, Ginny Sprang, Miriam Silman · 2018 · Journal of Child & Adolescent Trauma
69. From Uniform Definitions to Prediction of Risk: The Columbia Suicide Severity Rating Scale Approach to Suicide Risk Assessment
    Kelly Posner, Randy Subramany, Leora Amira, J. John Mann · 2014 · Springer eBooks
70. Dual Diagnosis Among Physicians: A Clinical Perspective
    María Dolores Braquehais, Pilar Lusilla, Miquel Jordi Bel, María Cecilia Navarro, Viviana Nasillo, Albert Díaz, Sergi Valero, Jaume Padrós, Eugeni Bruguera, Miguel Casas · 2014 · Journal of Dual Diagnosis
71. Effects of HIV-1 infection and aging on neurobehavioral functioning
    Mariana Cherner, Ronald J. Ellis, Deborah Lazzaretto, Corinna Young, Mónica Rivera Mindt, J. Hampton Atkinson, Igor Grant, Robert K. Heaton · 2004 · AIDS
72. The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts
    Andrew J. Levine, Charles H. Hinkin, Eric N. Miller, James T. Becker, Ola A. Selnes, Bruce A. Cohen · 2006 · Journal of Clinical and Experimental Neuropsychology
73. Stressful Childhood Experiences and Clinical Outcomes in People with Serious Mental Illness: a Gender Comparison in a Clinical Psychiatric Sample
    Kristina H. Muenzenmaier, Andres Ricardo Schneeberger, Dorothy M. Castille, Joseph Battaglia, Azizi A Seixas, Bruce G. Link · 2014 · Journal of Family Violence
74. Influence of gender and education on cocaine users in an outpatient cohort in Spain
    Nerea Requena-Ocaña, María Flores-López, Alicia San Martín, Nuria García‐Marchena, María Pedraz, Juan Jesús Ruiz, Antonia Serrano, Juan Suárez, Francisco Javier Pavón, Fernando Rodrı́guez de Fonseca et al. · 2021 · Scientific Reports
75. Childhood Abuse, Head Injuries, and Use of Medical Emergency Services in People with Severe Mental Illness
    Andres Ricardo Schneeberger, Kristina H. Muenzenmaier, Joseph Battaglia, Dorothy M. Castille, Bruce G. Link · 2012 · Journal of Aggression Maltreatment & Trauma
76. A Pilot Study of Interpersonal Psychotherapy (IPT) for Alcohol Dependent Women with Co-occurring Major Depression
    S. Gamble, Nancy L. Talbot, Sarah Cashman-Brown, Hua He, Ellen Poleshuck, G. Connors, K. Conner · 2013 · Substance Abuse
77. Concordance correlation in the measurements of time to event
    Xinhua Liu, Yunling E. Du, Jeanne A. Teresi, Deborah S. Hasin · 2004 · Statistics in Medicine
78. Effects of assisted outpatient treatment and health care services on psychotic symptoms
    Andres Ricardo Schneeberger, Christian G. Huber, Undine Emmi Lang, Kristina H. Muenzenmaier, Dorothy M. Castille, Matthias Jaeger, Azizi A Seixas, Julia Friederike Sowislo, Bruce G. Link · 2017 · Social Science & Medicine
79. Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients
    Pedro Fernando Araos, Rebeca Vidal, Esther O’Shea, María Pedraz, Nuria García‐Marchena, Antonia Serrano, Juan Suárez, Estela Castilla‐Ortega, Juan Jesús Ruiz, Rafael Campos‐Cloute et al. · 2019 · Scientific Reports
80. Depressive symptoms mediate the relationship between changes in emotion regulation during treatment and abstinence among women with alcohol use disorders.
    Cathryn Glanton Holzhauer, Stephanie A. Gamble · 2017 · Psychology of Addictive Behaviors
81. Methamphetamine-Using Parents: The Relationship Between Parental Role Strain and Depressive Symptoms
    Shirley J. Semple, Steffanie A. Strathdee, Jim Zians, Thomas L. Patterson · 2011 · Journal of Studies on Alcohol and Drugs
82. Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service
    Pedro Fernando Araos, Esperanza Vergara‐Moragues, Francisco González‐Sáiz, María Pedraz, Nuria García‐Marchena, Pablo Romero‐Sanchiz, Juan Jesús Ruiz, Rafael Campos‐Cloute, Antonia Serrano, Francisco Javier Pavón et al. · 2017 · Journal of Psychoactive Drugs
83. Cannabis use by people with severe mental illness – is it important?
    Zerrin Atakan · 2008 · Advances in Psychiatric Treatment
84. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk
    Maria Ferrara, Anya Umlauf, Chelsea Sanders, Jonathan M. Meyer, John Allen McCutchan, Nichole A. Duarte, Joseph Hampton Atkinson, Igor Grant, Ronald J. Ellis · 2014 · Psychiatry Research
85. Diagnosis and treatment of co-occurring affective disorders and substance use disorders
    Hugh Myrick, Jeff Cluver, Steven C Swavely, Hamilton Peters · 2004 · Psychiatric Clinics of North America
86. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use
    David S. Fink, Dvora Shmulewitz, Zachary L. Mannes, Malka Stohl, Ofir Livne, Melanie M. Wall, Deborah S. Hasin · 2022 · Journal of Psychiatric Research
87. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
    Nerea Requena-Ocaña, Pedro Fernando Araos, Pedro Jesús Serrano-Castro, María Flores-López, Nuria García‐Marchena, Begoña Oliver‐Martos, Juan Jesús Ruiz, Ana Gavito, Francisco Javier Pavón, Antonia Serrano et al. · 2023 · International Journal of Molecular Sciences
88. Evaluation of the Alcohol Use Disorders Identification Test and the Drug Use Disorders Identification Test among Patients at a Norwegian Psychiatric Emergency Ward
    Øystein Hoel Gundersen, Jon Mordal, Anne H. Berman, Jørgen G. Bramness · 2013 · European Addiction Research
89. ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders
    Wim van den Brink, S.A. Montgomery, Jan M. van Ree, Barbara J. Van Zwieten-Boot · 2006 · European Neuropsychopharmacology
90. A cross-sectional study of psychosocial and criminal factors associated with arrest in mentally ill female detainees.
    Howard M. Kravitz, James L. Cavanaugh, Sandra S Rigsbee · 2002 · PubMed
91. Substance Use Disorders
    Maxwell R. Christensen, Emma Anderson‐White, Lauren J. Ryan, Mia M. Ricardo, Beata A. Krembuszewski, Cody Sze, Craig E. Henderson · 2021 · Wiley eBooks
92. Psychological trauma exposure and co-morbid psychopathologies in HIV+men and women
    Robert P. Fellows, Nayeli A. Spahr, Desiree Byrd, Mónica Rivera Mindt, Susan Morgello · 2015 · Psychiatry Research
93. Even More Complex…. When Mental Disorder Meets Addiction in Youth: Dual Pathology
    Julio César Torales, João Maurício Castaldelli-Maia, Antônio Geraldo da Silva, Marcela Waisman Campos, Israel González, Iván Barrios · 2018 · Current Drug Research Reviews
94. Psicosis inducida por cannabis: características clínicas y su diferenciación con la esquizofrenia con y sin consumo de cannabis asociado
    David Rentero Martín, F. Árias, Sergio Sánchez-Romero, Gabriel Rubio, Roberto Rodríguez–Jiménez · 2020 · Adicciones
95. Gut microbiota dysbiosis is associated with worse emotional states in HIV infection
    Josué Pérez‐Santiago, María J. Marquine, Debralee Cookson, Rafael Giraud-Colón, Robert K. Heaton, Igor Grant, Ronald J. Ellis, Scott Lee Letendre, Scott N. Peterson · 2021 · Journal of NeuroVirology
96. Reliability and Validity of the Spanish Version of the Substance Dependence Severity Scale
    Antonio Vélez-Moreno, Francisco González‐Sáiz, Antonio José Rojas Tejada, Esperanza Torrico Linares, Fermín Fernández‐Calderón, Juan Ramírez López, Oscar Martin Lozano · 2014 · European Addiction Research
97. Neuropsychological Assessment Battery-Screening Module (S-NAB): Performance in treatment-seeking cocaine users
    Daniela Cannizzaro, Jennifer C. Elliott, Malka Stohl, Deborah S. Hasin, Efrat Aharonovich · 2014 · The American Journal of Drug and Alcohol Abuse
98. Assessment of Substance Use and Substance-Use Disorders in Schizophrenia
    Melanie E. Bennett · 2009 · Clinical Schizophrenia & Related Psychoses
99. Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders
    Diane Warden, Katherine Sanchez, Tracy L. Greer, Thomas James Carmody, Robrina Walker, Adriane M. dela Cruz, Marisa S.P. Toups, Chad D. Rethorst, Madhukar H. Trivedi · 2016 · Psychiatry Research
100. The Use of Visual Rating Scales to Quantify Brain MRI Lesions in Patients with HIV Infection
     Jessica Robinson‐Papp, Allison Navis, Mandip S. Dhamoon, Uraina S. Clark, Jose Gutierrez-Contreras, Susan Morgello · 2017 · Journal of Neuroimaging